Tci Wealth Advisors, Inc. Marker Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$0.24 - $4.58 $24 - $458	-100 Reduced 50.0%	100 $0
Q2 2021 Aug 02, 2021	SELL	$1.88 - $3.56 $940 - $1,780	-500 Reduced 71.43%	200 $1,000
Q1 2021 Apr 29, 2021	BUY	$1.47 - $3.29 $294 - $658	200 Added 40.0%	700 $2,000
Q4 2020 Jan 21, 2021	SELL	$1.36 - $1.75 $952 - $1,225	-700 Reduced 58.33%	500 $1,000
Q2 2020 Jul 20, 2020	SELL	$1.69 - $2.79 $2,535 - $4,185	-1,500 Reduced 55.56%	1,200 $2,000
Q1 2020 Apr 14, 2020	SELL	$1.59 - $3.35 $1,272 - $2,680	-800 Reduced 22.86%	2,700 $5,000
Q4 2019 Jan 27, 2020	BUY	$2.68 - $4.85 $1,876 - $3,394	700 Added 25.0%	3,500 $10,000
Q3 2019 Oct 17, 2019	BUY	$4.1 - $9.0 $2,869 - $6,300	700 Added 33.33%	2,800 $14,000
Q2 2019 Jul 23, 2019	BUY	$5.15 - $7.92 $4,635 - $7,128	900 Added 75.0%	2,100 $17,000
Q1 2019 Apr 11, 2019	BUY	$5.1 - $6.71 $6,120 - $8,052	1,200 New	1,200 $8,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $164M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.